Literature DB >> 18612164

Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.

Fadi Braiteh1, Razelle Kurzrock, Faye M Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612164     DOI: 10.1200/JCO.2008.16.9391

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.

Authors:  Carmine Pinto; Carlo Antonio Barone; Giampiero Girolomoni; Elvio Grazioso Russi; Marco Carlo Merlano; Daris Ferrari; Evaristo Maiello
Journal:  Oncologist       Date:  2011-01-27

2.  Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.

Authors:  Scott R Plotkin; Chris Halpin; Michael J McKenna; Jay S Loeffler; Tracy T Batchelor; Fred G Barker
Journal:  Otol Neurotol       Date:  2010-09       Impact factor: 2.311

3.  Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.

Authors:  Shan-Bing Wang; Kai-Jian Lei; Jia-Pei Liu; Yu-Ming Jia
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

4.  Iris heterochromia and unilateral eyelash hypertrichosis.

Authors:  Rajesh C Rao; Tiffany N S Ballard; Teresa C Chen
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

Review 5.  Skin toxicities associated with epidermal growth factor receptor inhibitors.

Authors:  Tianhong Li; Roman Perez-Soler
Journal:  Target Oncol       Date:  2009-05-19       Impact factor: 4.493

6.  Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas.

Authors:  Varun Goel; Shubhra Raina; D Chandragouda; Sajjan Singh; Vineet Talwar; Nivedita Patnaik
Journal:  Int J Trichology       Date:  2014-01

7.  Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review.

Authors:  Hua Zheng; Hongmei Zhang; Tongmei Zhang; Qunhui Wang; Fanbin Hu; Baolan Li
Journal:  Exp Ther Med       Date:  2016-06-16       Impact factor: 2.447

8.  A murine model of dry eye induced by topical administration of erlotinib eye drops.

Authors:  Qi-Chen Yang; Jing Bao; Cheng Li; Gang Tan; An-Hua Wu; Lei Ye; Lin-Hong Ye; Qiong Zhou; Yi Shao
Journal:  Int J Mol Med       Date:  2017-12-29       Impact factor: 4.101

9.  More is Not Always Better in Hair Growth Factors. Epidermal Growth Factor: Hair Growth Factor Involved in Alopecia Areata Pathogenesis.

Authors:  Asmaa M El-Refai; Doaa Mohamed Elhabak; Rana Atef Khashaba
Journal:  Int J Trichology       Date:  2020-09-19

10.  Erlotinib induced trichomegaly of the eyelashes.

Authors:  Sang-Hoon Jeon; Jeong-Seon Ryu; Gwang-Seong Choi; Jung-Soo Kim; Hea-Yoon Kwon; Min-Su Kim; Hae-Seong Nam; Jae-Hwa Cho; Seung-Min Kwak; Hong Lyeol Lee; Hyun-Jung Kim; Geun-Jeong Hong
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.